Lv4
420 积分 2023-05-05 加入
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials
2天前
已完结
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy
2天前
已完结
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
2天前
已完结
Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis
7天前
已完结
Novel NTCP ligand Dimeric Bile Acid Conjugated with ASO Reduce Hepatitis B Virus Surface Antigen in Vivo
7天前
已完结
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
8天前
已完结
The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity
8天前
已完结
Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3
8天前
已完结
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation
8天前
已完结
GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases
9天前
已完结
皖公网安备34019202002308
